Corrigendum to “Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)”
Year: 2025
Type: erratum
Source: Annals of Oncology
Institutions: Institut Gustave Roussy, Centre Oscar Lambret, Institut Curie, Institute Cancer De La Loire Lucien Neuwirth, Centre Antoine Lacassagne, Centre Georges François Leclerc, Centre Léon Bérard, Hôpital de la Timone, Institut Claudius Regaud, Institut Paoli-Calmettes, Institut Bergonié, Onco Lille
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415312307
